Latest DEF 14A proxy statements

Fractyl Health, Inc. is holding a special meeting on September 24, 2026, to seek stockholder approval for a reverse stock split ranging from 1-for-5 to 1-for-15 to maintain its Nasdaq listing.

Adial Pharmaceuticals, Inc. is holding its 2026 Annual Meeting to vote on crucial proposals, including the approval of share issuances related to its recent merger with Azora Therapeutics and amendments to equity incentive plans.

Soluna Holdings, Inc. is holding its 2026 Annual Meeting on October 16, 2026, to vote on proposals including a substantial increase in authorized common stock, director elections, and executive compensation.

Accuray Incorporated is holding a special meeting on October 6, 2026, to seek stockholder approval for a crucial financing transaction involving preferred stock issuance and warrants, alongside a reverse stock split to regain Nasdaq compliance.

Franklin Limited Duration Income Trust has issued its proxy statement for the 2026 Annual Shareholders Meeting on October 1, 2026, detailing the proposal for the election of four Trustees.

Unusual Machines, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for October 5, 2026, to be held virtually, with key proposals including the election of directors and a significant warrant grant to CEO Dr. Allan Evans.

YHN Acquisition I Limited is holding its Annual General Meeting to seek shareholder approval for amendments to its charter and trust agreement, aiming to extend the deadline for consummating a business combination.

Multiple RiverNorth Funds have issued a joint proxy statement detailing the upcoming Annual Meeting of Stockholders on September 22, 2026, primarily for the election of Directors.

Multiple RiverNorth Funds have issued a joint proxy statement detailing the upcoming Annual Meeting of Stockholders on September 22, 2026, primarily for the election of Directors.

Multiple RiverNorth Funds have issued a joint proxy statement detailing the upcoming Annual Meeting of Stockholders on September 22, 2026, primarily for the election of Directors.

Multiple RiverNorth Funds have issued a joint proxy statement detailing the upcoming Annual Meeting of Stockholders on September 22, 2026, primarily for the election of Directors.

Multiple RiverNorth Funds have issued a joint proxy statement detailing the upcoming Annual Meeting of Stockholders on September 22, 2026, primarily for the election of Directors.

Multiple RiverNorth Funds have issued a joint proxy statement detailing the upcoming Annual Meeting of Stockholders on September 22, 2026, primarily for the election of Directors.

Multiple RiverNorth Funds have issued a joint proxy statement detailing the upcoming Annual Meeting of Stockholders on September 22, 2026, primarily for the election of Directors.

Multiple RiverNorth Funds have issued a joint proxy statement detailing the upcoming Annual Meeting of Stockholders on September 22, 2026, primarily for the election of Directors.

CNS Pharmaceuticals, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for September 30, 2026, to elect directors, ratify auditors, and seek approval for amendments to its 2020 Stock Plan.

Kidz AI Inc. is holding a special meeting on September 10, 2026, to vote on proposals including a significant increase in authorized Class A common stock, approval of a new equity incentive plan, and ratification of its auditor.

Wetouch Technology Inc. is holding a special meeting on September 4, 2026, to seek shareholder approval for the issuance of common stock to Qixun Technology and Qihong Technology, which will significantly increase the beneficial ownership of CEO Guangde Cai.

MiniMed Group, Inc. has announced its 2026 Annual Meeting of Stockholders, detailing key proposals including director elections, auditor ratification, and executive compensation votes.

VivoSim Labs announces its 2026 Annual Meeting of Stockholders, detailing proposals including director elections, auditor ratification, executive compensation approval, a reverse stock split, equity plan amendments, and warrant adjustments.

Venu Holding Corporation has issued its proxy statement for the upcoming Annual Meeting of Shareholders on September 23, 2026, detailing proposals for director elections, debt financing, and incentive plan amendments.

NextTrip, Inc. has filed a proxy statement detailing proposals for its 2027 Annual Meeting of Stockholders, including the election of directors, ratification of auditors, and crucial approvals for share issuances that could result in significant dilution.

Neogen Corporation has filed its Proxy Statement for the 2026 Annual Meeting of Shareholders, detailing proposals for director elections, executive compensation, auditor ratification, and equity plan amendments.

Richardson Electronics, Ltd. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for October 6, 2026, detailing proposals for director elections, auditor ratification, and executive compensation.

Howard Hughes Holdings Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for September 30, 2026, in New York City, detailing director nominations and executive compensation votes.

Advent Convertible and Income Fund announces its Annual Meeting of Shareholders scheduled for September 16, 2026, to elect Trustees and address other business.

BayFirst Financial Corp. has announced its 2026 Annual Meeting of Shareholders, scheduled for September 22, 2026, to elect 12 directors and address other business.

OneMedNet Corporation has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals including a potential reverse stock split, an equity incentive plan increase, director elections, and auditor ratification.

Neighborhood Intelligence, Inc. (formerly Bed Bath & Beyond) is holding a special meeting to seek stockholder approval for the issuance of shares related to its acquisition of The Container Store.

Pelthos Therapeutics Inc. has announced its 2026 Annual Meeting of Shareholders, scheduled for September 29, 2026, to elect directors, ratify auditors, and approve a new equity incentive plan.